Norges Bank’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-28,900
| Closed | -$257K | – | 1705 |
|
|
2024
Q2 | $257K | Sell |
28,900
-95,400
| -77% | -$849K | ﹤0.01% | 1910 |
|
|
2024
Q1 | $1.26M | Buy |
124,300
+92,387
| +289% | +$936K | ﹤0.01% | 1777 |
|
|
2023
Q4 | $321K | Sell |
31,913
-1,057,624
| -97% | -$10.6M | ﹤0.01% | 1916 |
|
|
2023
Q3 | $10.2M | Buy |
1,089,537
+312,387
| +40% | +$2.93M | ﹤0.01% | 1467 |
|
|
2023
Q2 | $19.1M | Buy |
777,150
+140,200
| +22% | +$3.44M | ﹤0.01% | 1276 |
|
|
2023
Q1 | $14.8M | Sell |
636,950
-91,610
| -13% | -$2.13M | ﹤0.01% | 1414 |
|
|
2022
Q4 | $18.4M | Buy |
728,560
+112,693
| +18% | +$2.85M | ﹤0.01% | 1309 |
|
|
2022
Q3 | $11.9M | Buy |
615,867
+17,503
| +3% | +$337K | ﹤0.01% | 1464 |
|
|
2022
Q2 | $15.2M | Buy |
598,364
+45,247
| +8% | +$1.15M | ﹤0.01% | 1374 |
|
|
2022
Q1 | $14.2M | Buy |
553,117
+55,697
| +11% | +$1.43M | ﹤0.01% | 1561 |
|
|
2021
Q4 | $20.8M | Buy |
497,420
+103,751
| +26% | +$4.34M | ﹤0.01% | 1454 |
|
|
2021
Q3 | $17.1M | Buy |
393,669
+101,994
| +35% | +$4.44M | ﹤0.01% | 1573 |
|
|
2021
Q2 | $13.8M | Sell |
291,675
-213,852
| -42% | -$10.1M | ﹤0.01% | 1684 |
|
|
2021
Q1 | $25.9M | Sell |
505,527
-65,717
| -12% | -$3.37M | 0.01% | 1377 |
|
|
2020
Q4 | $15.3M | Sell |
571,244
-68,094
| -11% | -$1.82M | ﹤0.01% | 1647 |
|
|
2020
Q3 | $21.9M | Sell |
639,338
-173,578
| -21% | -$5.96M | 0.01% | 1363 |
|
|
2020
Q2 | $33.3M | Buy |
+812,916
| New | +$33.3M | 0.01% | 1122 |
|
|
2020
Q1 | – | Sell |
-25,000
| Closed | -$314K | – | 2074 |
|
|
2019
Q4 | $314K | Buy |
+25,000
| New | +$314K | ﹤0.01% | 2067 |
|